Abstract
Antacid (AA) in a very low dose (88 mmol/day) was compared to the standard 800-mg dose of cimetidine in healing duodenal ulcers. The influence of sex, age, symptom duration at entry, night pain, smoking, coffee consumption, and alcohol on ulcer healing was studied. The antacid was given in two different schedules: group I-20 ml 1 hr after breakfast and at bedtime; group II-10 ml 1 hr after breakfast and lunch and 20 ml at bedtime. Cimetidine (group III) was given in two divided doses: 400 mg 1 hr after breakfast and 400 mg at bedtime. Endoscopic control was performed after four weeks and, if necessary, after eight weeks of treatment. The healing rate after four weeks of treatment was, respectively, for groups I, II, and III, 45.5%, 55.8%, and 69.4% (group I=group II, and group III different from groups I and II). After eight weeks of treatment the healing rate was 61.5%, 80.8%, and 88.0% for groups I, II, and III, respectively (group II=group III, and group I different from groups II and III). Except for group I, smoking did not influence healing rate. Age, sex, symptoms at entry, night pain, and coffee consumption did not influence the treatment results. The authors concluded that the very low dose of magaldrate (88 mmol/day), when administered in three divided doses (10 ml after breakfast and lunch and 20 ml at bedtime) for eight weeks was as effective as 800 mg of cimetidine (400 mg twice a day) in healing duodenal ulcer.
Similar content being viewed by others
References
Kumar N, Vij JC, Karol A, Anand BS: Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut 25:1199–1202, 1984
Lam SK, Lam KC, Lai CL, Yeung CK, Yam LYC, Wong WS: Treatment of duodenal ulcer with antacid and sulpiride. A double blind controlled study. Gastroenterology 76:315–322, 1979
Weberg R, Berstad A, Lange O, et al: Duodenal ulcer healing with four antacids tablets daily. Scand J Gastroenterol 20:1041–1045, 1985
Zaterka S, Massuda HK, Eisig JN, Dallaverde Neto E, Miszputen SJ, Leitão OR, Jorge JL, Cordeiro F, Castro LP, Coelho LGV, Castro FJ, Vieira WL: Comparison of low and very low antacid doses in the treatment of duodenal peptic ulcer. Curr Ther Res 47:554–559, 1990
Sakita T: Endoscopic in the diagnosis of early ulcer cancer. Clin Gastroenterol 2:345–360, 1973
Richardson CT, Peterson WL: Clinical pharmacology of antacids.In Antacids in Peptic Ulcer Disease. State of the Art. G Bianchi Porro, CR Richardson (eds). New York, Raven Press, pp 3–16, 1988
Tarnawski A, Hollander D, Cumming D, Krausc WJ, Gergely H, Zipser RD: Are antacids acid neutralizers only? Histologic, ultrastructural and functional changes in normal gastric mucosa induced by antacids. Gastroenterology 86:1276, 1984
Lanz R, Postius S, Szehenyi I, Brune K: PGE2 release from cultured macrophages induced by antacids and sucralfate. Gastroenterology 88:1464, 1985
Preclik G, Stange EF, Gerber K, Fetzer G, Horn H, Ditschuneit H: Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut 30:148–151, 1989
Konturek SJ, Brzozowski T, Drozdowicz D, Dembinski A, Navert C: Healing of chronic gastroduodenal ulceration by antacids. Dig Dis Sci 35:1121–1129, 1990
Konturek SJ, Dembinski A, Warsecha Z, Bielanski W, Brzozowski T, Drozdowicz D: Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. Gut 29:894–902, 1986
Berstad A, Alexander B, Weberg R, Serck-Hanseen A, Holland S, Hirschowitz BI: Antacids reduceCampylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes. Gastroenterology 95:619–624, 1988
Zaterka S, Eisig JN, Arakaki E, Massuda HK, Chinzon D: Gastrite e infecção peloHelicobacter pylori: Influência do magaldrato x placebo. GED 9:140, 1990
Weberg R, Aubert E, Dahlberg O, Dybdahl J, Ellekjara E, Farup PG, Hovdenak N, Lange O, Melsom M, Stallemo O, Vetvik KR, Berstad A: Low-dose antacids or cimetidine for duodenal ulcer? Gastroenterology 95:1465–1469, 1988
Berstad A, Weberg R: Antacids for peptic ulcer: Do we have anything better? Scand J Gastroenterol 21(suppl 125):32–39, 1986
Rydning A, Ragnar W, Lange O, Berstad A: Healing of benign gastric ulcer with low-dose antacids and fiber diet. Gastroenterology 91:56–61, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zaterka, S., Cordeiro, F., Lyra, L.G.C. et al. Very-low dose antacid in treatment of duodenal ulcer. Digest Dis Sci 36, 1377–1383 (1991). https://doi.org/10.1007/BF01296802
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296802